Maria Teresa Ortiz-Melo

Dr. Maria Teresa Ortiz-Melo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
KMKaren Vanessa Fernández Muñoz
Karen Vanessa Fernández Muñoz
ÁBÁngel Ángel Sánchez Barrera
Ángel Ángel Sánchez Barrera
MMMARCO ANTONIO MERAZ-RÍOS
MARCO ANTONIO MERAZ-RÍOS
JRJose Luis Reyes
Jose Luis Reyes
EPEloy Perez-Yepez
Eloy Perez-Yepez
MMMonica Graciela Mendoza-Rodriguez
Monica Graciela Mendoza-Rodriguez
Colorectal cancer (CRC) is one of the deadliest neoplasia. Intrinsic or acquired resistance is the main cause of failure of therapy regimens that leads to relapse and death in CRC patients. The widely used chemotherapeutic agent 5-fluorouracil (5-FU) remains the mainstay for therapeutic combinations. Unfortunately, chemotherapeutic resistance and side effects are frequent events that compromise the success of these therapies; the dysregulation of enzymes that regulate 5-FU metabolism increases the expression and activity of efflux pumps. Additional tumor cell adaptations such as epithelial–mesenchymal transition (EMT), autophagy shaping of the tumor microenvironment, and inflammation contribute to chemoresistance. Finding new strategies and alternatives to enhance conventional chemotherapies has become necessary. Recently, the study of natural compounds has been gaining strength as an alternative to chemotherapeutics in different cancers. Curcumin, trimethylglycine, resveratrol, artemisinin, and some helminth-derived molecules, among others, are some natural compounds studied in the context of CRC. This review discusses the main benefits, mechanisms, advances, and dark side of conventional chemotherapeutics currently evaluated in CRC treatment. We also analyzed the landscape of alternative non-conventional compounds and their underlying mechanisms of action, which could, in the short term, provide fundamental knowledge to harness their anti-tumor effects and allow them to be used as alternative adjuvant therapies.

6 December 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Maria Teresa Ortiz-MeloMaria Teresa Ortiz-Melo
Maria Teresa Ortiz-Melo
JCJorge E Campos
Jorge E Campos
ESErika Sánchez-Guzmán
Erika Sánchez-Guzmán
MHMaría Esther Herrera-Aguirre
María Esther Herrera-Aguirre
FCFederico Castro-Munozledo
Federico Castro-Munozledo
In recent years, different laboratories have provided evidence on the role of miRNAs in regulation of corneal epithelial metabolism, permeability and wound healing, as well as their alteration after surgery and in some ocular pathologies. We searched the available databases reporting miRNA expression in the human eye, looking for miRNAs highly expressed in central cornea, which could be crucial for maintenance of the epithelial phenotype. Using the rabbit RCE1(5T5) cell line as a model of corneal epithelial differentiation, we describe the participation of miR-141-3p as a possible negative regulator of the proliferative/migratory phenotype in corneal epithelial cells. The expression of miR-141-3p followed a time course similar to the differentiation-linked KRT3 cytokeratin, being delayed 24–48 hours relative to PAX6 expression; such result suggested that miR-141-3p only regulates the expression of terminal phenotype. Inhibition of miR-141-3p led to increased cell proliferation and motility, and induced the expression of molecular makers characteristic of an Epithelial Mesenchymal Transition (EMT). Comparison between the transcriptional profile of cells in which miR-141-3p was knocked down, and the transcriptomes from proliferative non-differentiated and differentiated stratified epithelia suggest that miR-141-3p is involved in the expression of terminal differentiation mediating the arrest of cell proliferation and inhibiting the EMT in highly motile early differentiating cells.

20 September 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
ÁBÁngel Ángel Sánchez Barrera
Ángel Ángel Sánchez Barrera
KMKaren Vanessa Fernández Muñoz
Karen Vanessa Fernández Muñoz
MMMónica G. Mendoza-Rodríguez
Mónica G. Mendoza-Rodríguez
Maria Teresa Ortiz-MeloMaria Teresa Ortiz-Melo
Maria Teresa Ortiz-Melo
JPJazmín Areli Carrillo Pérez
Jazmín Areli Carrillo Pérez
Luis I TerrazasLuis I Terrazas
Luis I Terrazas
Worldwide, colorectal cancer (CRC) is the third-most common cancer and the second-leading cause of cancer-related deaths. The inflammatory response initiated by pathogens, environmental and dietary factors, and inflammatory bowel diseases can promote the formation of colorectal tumors. The hygiene hypothesis proposes an inverse link between inflammatory diseases and early childhood exposure to pathogens, with a significant negative correlation between chronic inflammatory diseases and helminth infections. On the other hand, it is also known that several pathogens may influence or even cause the development of cancer, including helminth infections. How do helminth infections influence CRC outcomes? The existing literature presents two different perspectives. Experimental studies in CRC models suggest that helminths may accelerate disease progression and lead to worse outcomes (such as Schistosoma and Trichuris sp.), while others indicate that helminths could help reduce tumor burden (such as Taenia sp.). This review focuses on helminths’ pro- and anti-tumorigenic effects and their derivatives, specifically in CRC. We provide a comprehensive understanding of how helminths impact the macroscopic, histopathological, immunological, and molecular aspects of CRC.

26 May 2026 in Botanical Sciences
Verified
Journal Article
Open access
MVMiguel Ángel Verástegui-Vidal
Miguel Ángel Verástegui-Vidal
RBRobert Bye Boettler
Robert Bye Boettler
CFCesar Flores
Cesar Flores
YPYolanda Pozos-Ruiz
Yolanda Pozos-Ruiz
Maria Teresa Ortiz-MeloMaria Teresa Ortiz-Melo
Maria Teresa Ortiz-Melo
VCVíctor Manuel Chávez-Ávila
Víctor Manuel Chávez-Ávila
Background: Cosmos atrosanguineus is a perennial herbaceous plant with tuberous rhizomes endemic to Mexico. It is sterile and does not produce seeds, requiring alternative propagation methods. Questions: Can in vitro techniques be used to develop microrhizomes and microtubers as propagules for Cosmos atrosanguineus? Studied species: The study focused on C. atrosanguineus explants cultured under controlled in vitro conditions, with emphasis on rhizome and tuber development. Study site: Experiments were conducted in vitro under laboratory conditions. Methods: Culture media were supplemented with auxins, particularly 1-Naphthaleneacetic Acid (NAA), and with varying concentrations of sucrose. Morphological, anatomical, and biochemical analyses were performed to confirm tuberization. Additionally, transpiration rates were compared between acclimatized plantlets and those regenerated from in vitro microrhizomes. Results: Supplementation with 1 mg/L NAA promoted microrhizome development, while 12.0 % sucrose stimulated microtuber induction. Anatomical characterization of tuberized microrhizomes confirmed their similarity to the naturally tuberizing species Cosmos pringlei. Plantlets derived from microrhizomes successfully acclimatized ex vitro, showing functional transpiration. Conclusions: The in vitro generation of microrhizomes and microtubers represents a viable propagation strategy for C. atrosanguineus. These propagules are suitable for ex vitro establishment, offering an effective alternative for conserving and propagating this endemic sterile species.